Variable domain structure of κIV human light chain Len: High homology to the murine light chain McPC603

Molecular Immunology

Volumn 34, Issue 18, 1997, Pages 1291-1301

  Huang, De Bin ^a,c   Chang, Chong Hwan ^a,d   Ainsworth, Clint ^a   Johnson, George ^a   Solomon, Alan ^b   Stevens, Fred J ^a   Schiffer, Marianne ^a  

^a ARGONNE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUPONT COMPANY   (United States)

Author keywords

Amyloid; Humanization; Immunoglobulin; Protein stability; X ray diffraction

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CRYSTAL STRUCTURE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; EPITOPES; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

ANIMALIA; MURINAE;

EID: 0031390641     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00002-9     Document Type: Article

References (49)

1. Belloti, V. and Merlini, G. (1996) Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition. Nephrol. Dial. Transplant 11, 1708-1711.
2. Brünger, A. T., Krukowski, A. and Erickson, J. W. (1990) Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta Cryst. A46, 585-593.
3. Brünger, A. T. (1992) X-PLOR, Version 3.1. A System for X-Ray Crystallography and NMR. Yale University Press, New Haven.
4. Brünger, A. T. (1997) The free R value: A more objective statistic for crystallography. Methods Enzym. 277, 366-396.
5. Claflin, J. L., Berry, J., Flaherty, D. and Dunnick, W. (1987) Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii. Immunol. 138, 3060-3068.
6. Co, M. S. and Queen, C. (1991) Humanized antibodies for therapy. Nature 351, 501-502.
7. Colman, P. M., Schramm, H. J. and Guss, J. M. (1977) Crystal and molecular structure of the dimer of variable domains of the Bence-Jones protein ROY. J. Mol. Biol. 116, 73-79.
8. Colman, P. M., Laver, W. G., Varghese, J. H., Baker, A. T., Tulloch, P. A., Air, G. M. and Webster, R. G. (1987) Three-dimensional structure of a complex of antibody with influenza-virus neuraminidase. Nature 326, 358-363.
9. Creamer, T. P. and Rose, G. D. (1992) Side-chain entropy opposes α-helix formation but rationalizes experimentally determined helix-forming propensities. Proc. Natl. Acad. Sci. U.S.A. 89, 5937-5941.
10. Denoroy, L., Deret, S. and Aucouturier, P. (1994) Over representation of the VκIV subgroup in light chain deposition disease. Immunol. Let. 42, 63-66.
11. Epp, O., Lattman, E. E., Schiffer, M., Huber, R. and Palm, W. (1975) The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0 Å resolution. Biochemistry 14, 4943-4952.
12. Fehlhammer, H., Schiffer, M., Epp, O., Colman, P. M., Lattman, E. E., Schwager, P., Steigemann, W. and Schramm, H. J. (1975) The structure determination of the variable portion of the Bence-Jones protein AU. Biophys. Struct. Mechanism 1, 139-146.
13. Furey, W. Jr., Wang, B. C., Yoo, C. S. and Sax, M. (1983) Structure of a novel Bence-Jones protein (RHE) fragment at 1.6 Å resolution. J. Mol. Biol. 167, 661-692.
14. Gallo, G., Picken, M., Buxbaum, J. and Frangione, B. (1989) The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias. Semin. Hematol. 26, 234-245.
15. L domain of the antibody McPC603 produced in E. coli. J. Mol. Biol. 213, 613-615.
16. He, X. M., Rueker, F., Casale, E. and Carter, D. C. (1992) Structure of a human monoclonal antibody Fab fragment against GP41 of human immunodeficiency virus type I. Proc. Nat. Acad. Sci. U.S.A. 89, 7154-7158.
17. Hendrickson, W. A. (1985) Stereochemically restrained refinement of macromolecular structures. Meth. Enzymol. 115, 252-270.
18. Huang, D.-B., Chang, C.-H., Ainsworth, C., Brünger, A. T., Eulitz, M., Solomon, A., Stevens, F. J. and Schiffer, M. (1994) Comparison of two homologous proteins: Structural origin of altered domain interactions in immunoglobulin light-chain dimers. Biochemistry 33, 14848-14857.
19. Jones, R. A., Zou, J. -Y., Cowan, S. W. and Kjeldgaard, M. (1991) Improved methods for building protein models in electron density maps and the location of errors in these methods. Acta Cryst. A47, 110-119.
20. Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S. and Foeller, C., Eds. (1991) In Sequences of Proteins of Immunological Interest, 5th ed. National Institutes of Health, Bethesda, MD.
21. Karlin, S., Zuker, M. and Brocchieri, L. (1994) Measuring residue associations in protein structures. Possible implications for protein folding. J. Mol. Biol. 239, 227-248.
22. Kashmiri, S. V. S., Shu, L., Padlan, E. A., Milenic, D. E., Schlom, J. and Hand, P. H. (1995) Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma 14, 461-473.
23. Klein, R., Jaenichen, R. and Zachau, H. G. (1993) Expressed human immunoglobulin κ genes and their hypermutation. Eur. J. Immunol. 23, 3248-3271.
24. Klobeck, H. G., Bornkamm, G. W., Combriato, G., Mocikat, R., Pohlenz, H. D. and Zachau, H. G. (1985) Subgroup κIV of human immunoglobulin κ light chains is encoded by a single germline gene. Nucleic Acids Res. 13, 6515-6529.
25. Kroemer, G., Helmberg, A., Bernot, A., Auffray, C. and Kofler, R. (1991) Evolutionary relationship between human and mouse immunoglobulin kappa light chain variable region genes. Immunogenetics 33, 42-49.
26. Laskowski, R. A., MacArthur, M. W., Moss, D. S. and Thornton, J. M. (1993) PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.
27. Lee, B. and Richards, F. M. (1971) Solvent accessibility of groups in proteins. J. Mol. Biol. 55, 379-400.
28. Luzzati, V. (1952) Traitement statistique des erreurs dans la détermination des structures cristallines. Acta Cryst. 5, 802-810.
29. Matthews, B. W. (1968) Solvent content of protein crystals. J. Mol. Biol. 33, 491-497.
30. Navaza, J. (1994) AMoRe: An automated package for molecular replacement. Acta Cryst. A50, 157-163.
31. Padlan, A. E. (1991) A possible procedure for reducing the immunogeneticity of antibody variable domains while preserving their ligand-binding properties. Mol. Immunol.28, 489-498.
32. Palm, W. and Hilschmann, N. (1975) Die Primärstruktur einer kristallinen monoklonalen immunglobulin-L-Kette vom κ-Typ, subgruppe I (Bence-Jones-Protein Rei). Hoppe-Seyler's Z. Physiol. Chem. 356, 167-191.
33. Riechmann, L., Clark, M., Waldmann, H. and Winter, G. (1988) Reshaping human antibodies for therapy. Nature 332, 323-327.
34. Rudikoff, S., Satow, Y., Padlan, E., Davies, D, and Potter, M. (1981) Kappa chain structure from a crystallized murine Fab′: Role of joining segment in hapten binding. Molec. Immunol. 18, 705-711.
35. Satow, Y., Cohen, G. H., Padlan, E. A. and Davies, D. R. (1986) Phosphocholine binding Fab McPC603. J. Mol. Biol. 190, 593-604.
36. Schiffer, M. (1996) Molecular anatomy and the pathological expression of antibody light chains. Am. J. Pathol. 148, 1339-1344.
37. Schneider, M. and Hilschmann, N. (1974) The primary structure of a monoclonal immunoglobulin L-chain of κ-type, subgroup IV (Bence-Jones protein Len): A new subgroup of the κ-type L-chain. Hoppe-Seyler's Z. Physiol. Chem. 355, 1164-1168.
38. Schormann, N., Murrell, J. R., Liepnieks, J. J. and Benson, M. D. (1995) Tertiary structure of an amyloid immunoglobulin light chain protein: A proposed model for amyloid fibril formation. Proc. Natl. Acad. Sci. U.S.A. 92, 9490-9494.
39. Singer, I. I., Kawka, D. W., DeMartino, J. A., Daugherty, B. L., Elliston, K. O., Alves, K., Bush, B. L., Cameron, P. M., Cuca, G. C., Davies, P., Forest, M. J., Kazazis, D. M., Law, M-F., Lenny, A. B., MacIntyre, D. E., Meurer, R., Padlan, E. A., Pandya, S., Schmidt, J. A., Seamans, T. C., Scott, S., Silberklang, M., Williamson, A. R. and Mark, G. E. (1993) Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences. J. Immunol. 150, 2844-2857.
40. Solomon, A. and McLaughlin, C. L. (1969) Bence-Jones proteins and light chains of immunoglobulins. I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves. J. Biol. Chem. 244, 3393-3404.
41. Solomon, A. and Weiss, D. T. (1993) Ominous consequences of immunoglobulin deposition. N. Engl. J. Med. 329, 1422-1423.
42. Solomon, A., McLaughlin, C. L., Wei, C. H. and Einstein J. R. (1970) Bence-Jones proteins and light chains of immunoglobulins. V. X-ray crystallographic investigation of the amino-terminal half of a κ Bence-Jones protein. J. Biol. Chem. 245, 5289-5291.
43. Steipe, B., Plhckthun, A. and Huber, R. (1992) Refined crystal structure of a recombinant immunoglobulin domain and a complementary-determining region 1-grafted mutant. J. Mol. Biol. 225, 739-753.
44. Steipe, B., Schiller, B., Plükthun A. and Steinbacher, S. (1994) Sequence statistics reliably predict stabilizing mutations in a protein domain. J. Mol. Biol. 240, 188-192.
45. Stevens, F. J., Solomon, A. and Schiffer, M. (1991) Bence-Jones proteins: A powerful tool for the fundamental study of protein chemistry and pathophysiology. Biochemistry 30, 6803-6805.
46. Stevens, F. J., Myatt, E. A., Chang, C-H., Westholm, F. A., Eulitz, M., Weiss, D. T., Murphy, C., Solomon, A. and Schiffer, M. (1995) A molecular model for self-assembly of amyloid fibrils: Immunoglobulin light chains. Biochemistry 34, 10697-10702.
47. Tomlinson, I. M., Cox, J. P. L., Gherardi, E., Lesk, A. M. and Chothia, C. (1995) The structural repertoire of the human Vκ domain. EMBO J. 14, 4628-4638.
48. Wells, J. A. (1990) Additivity of mutational effects in proteins. Biochemistry 29, 8509-8517.
49. Wilkins Stevens, P., Raffen, R., Hanson, D. K., Deng, Y-L., Berrios-Hammond, M., Westholm, F. A., Murphy, C., Eulitz, M., Wetzel, R., Solomon, A., Schiffer, M. and Stevens, F. J. (1995) Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Protein Sci. 4, 421-432.